Clinical Trial Detail

NCT ID NCT01182285
Title A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

thyroid gland cancer

Therapies

Liothyronine sodium

Valproic acid

Age Groups: adult

No variant requirements are available.